METTL1 and esophageal squamous cell carcinoma: These findings reveal a new tRNA modified-mediated translation regulation mechanism, linking the translation mechanism to the autophagy mechanism, and suggest that METTL1 and its downstream signaling pathways may be potential targets for ESCC therapy.